For example, increased EIF5A2 expression is an independent molecular marker for reduced survival in patients with ovarian carcinoma 22 and EIF4E is a useful marker for malignant transformation of cervical squamous cells 23. This evidence concerns the gene EIF4E and ovarian carcinoma.